Browsing by Author Naud P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 9 of 9
PreviewIssue DateTitleAuthor(s)AdvisorType
2015Post Hoc Analysis Of The Patricia Randomized Trial Of The Efficacy Of Human Papillomavirus Type 16 (hpv-16)/hpv-18 As04-adjuvanted Vaccine Against Incident And Persistent Infection With Nonvaccine Oncogenic Hpv Types Using An Alternative Multiplex Type-specific Pcr Assay For Hpv DnaStruyf F.; Colau B.; Wheeler C.M.; Naud P.; Garland S.; Quint W.; Chow S.-N.; Salmeron J.; Lehtinen M.; Del Rosario-Raymundo M.R.; Paavonen J.; Teixeira J.C.; Maria Julieta Germar M.J.; Peters K.; Skinner R.; Limson G.; Castellsague X.; Poppe W.A.J.; Ramjattan B.; Klein T.D.; Schwarz T.F.; Chatterjee A.; Tjalma W.A.A.; Diaz-Mitoma F.; Lewis D.J.M.; Harper D.M.; Molijn A.; Van Doorn L.-J.; David M.-P.; Dubin G.-Artigo de periódico
2014Risk Of Newly Detected Infections And Cervical Abnormalities In Women Seropositive For Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis Of The Control Arm Of PatriciaCastellsague X.; Naud P.; Chow S.-N.; Wheeler C.M.; Germar M.J.V.; Lehtinen M.; Paavonen J.; Jaisamrarn U.; Garland S.M.; Salmeron J.; Apter D.; Kitchener H.; Teixeira J.C.; Skinner S.R.; Limson G.; Szarewski A.; Romanowski B.; Aoki F.Y.; Schwarz T.F.; Poppe W.A.J.; Bosch F.X.; De Carvalho N.S.; Peters K.; Tjalma W.A.A.; Safaeian M.; Raillard A.; Descamps D.; Struyf F.; Dubin G.; Rosillon D.; Baril L.-Artigo de periódico
2011Risk Estimates For Persistent High-risk Human Papillomavirus Infections As Surrogate Endpoints Of Progressive Cervical Disease Critically Depend On Reference Category: Analysis Of The Combined Prospective Cohort Of The New Independent States Of The Former Soviet Union And Latin American Screening StudiesSyrjanen K.; Shabalova I.; Naud P.; Kozachenko V.; Derchain S.; Zakharchenko S.; Roteli-Martins C.; Nerovjna R.; Longatto-Filho A.; Kljukina L.; Tatti S.; Branovskaja M.; Hammes L.S.; Branca M.; Grunjberga V.; Erzen M.; Juschenko A.; Costa S.; Sarian L.; Podistov J.; Syrjanen S.-Artigo de periódico
2009Up-regulation Of Plasminogen Activator Inhibitor-2 Is Associated With High-risk Hpv And Grade Of Cervical Lesion At Baseline But Does Not Predict Outcomes Of High-risk Hpv Infections Or Incident CinSyrjanen S.; Naud P.; Sarian L.; Derchain S.; Roteli-Martins C.; Longatto-Filho A.; Tatti S.; Branca M.; Erzen M.; Hammes L.S.; Costa S.; Syrjanen K.-Artigo de periódico
2007Association Between Age At First Sexual Intercourse And Subsequent Human Papillomavirus Infection: Results Of A Brazilian Screening Program [associação Entre Idade Ao Início Da Atividade Sexual E Subsequente Infecção Por Papilomavírus Humano: Resultados De Um Programa De Rastreamento Brasileiro]Roteli-Martins C.M.; Filho A.L.; Hammes L.S.; Derchain S.F.M.; Naud P.; De Matos J.C.; Etlinger D.; Sarian L.; Gontijo R.C.; Maeda M.Y.S.; Syrjanen K.J.-Artigo de periódico
2008Value Of Conventional Pap Smear, Liquid-based Cytology, Visual Inspection And Human Papillomavirus Testing As Optional Screening Tools Among Latin American Women < 35 And ≥ 35 Years Of Age: Experience From The Latin American Screening StudySyrjanen K.; Derchain S.; Roteli-Martins C.; Longatto-Filho A.; Hammes L.S.; Sarian L.; Naud P.; Tatti S.; Branca M.; Erzen M.; Matos J.; Gontijo R.; Braganca J.; Arlindo F.; Maeda M.Y.S.; Lorincz A.; Dores G.B.; Costa S.; Syrjanen S.-Artigo de periódico
2010Up-regulation Of Lipocalin 2 Is Associated With High-risk Human Papillomavirus And Grade Of Cervical Lesion At Baseline But Does Not Predict Outcomes Of Infections Or Incident Cervical Intraepithelial NeoplasiaSyrjanen S.; Naud P.; Sarian L.; Derchain S.; Roteli-Martins C.; Tatti S.; Branca M.; Erzen M.; Hammes L.S.; Costa S.; Longatto-Filho A.; Syrjanen K.-Artigo de periódico
2010Up-regulation Of 14-3-3σ (stratifin) Is Associated With High-grade Cin And High-risk Human Papillomavirus (hpv) At Baseline But Does Not Predict Outcomes Of Hr-hpv Infections Or Incident Cin In The Lams* StudySyrjanen S.; Naud P.; Sarian L.; Derchain S.; Roteli-Martins C.; Longatto-Filho A.; Tatti S.; Branca M.; Erzen M.; Hammes L.S.; Costa S.; Syrjanen K.-Artigo de periódico
2012Sustained Immunogenicity And Efficacy Of The Hpv-16/18 As04-adjuvanted Vaccine: Up To 8.4 Years Of Follow-upRoteli-Martins C.M.; Naud P.; De Borba P.; Teixeira J.C.; De Carvalho N.S.; Zahaf T.; Sanchez N.; Geeraerts B.; Descamps D.-Artigo de periódico